Concepedia

Stefan Wietek

SW

4

Publications

225

Citations

4

H-Index

2013

Active since

Affiliations

Octapharma (Austria)(Current)

Stefan Wietek is an author at Octapharma (Austria) specializing in dementia, medicine, and treatment.

ORCID

Top concepts

Publications per year

2013–2021

4

Publications

4

Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial

Richard Dodel, Axel Rominger, Peter Bartenstein et al. · The Lancet Neurology · 2013 · 183 citations · Full text

, , +12

Tolerability and safety of Octagam® (IVIG): a post-authorization safety analysis of four non-interventional phase IV trials

Wolfgang Frenzel, Stefan Wietek, Tor‐Einar Svae et al. · International Journal of Clinical Pharmacology and Therapeutics · 2016 · 18 citations · Full text

Efficacy and safety of a new intravenous immunoglobulin (Panzyga<sup>®</sup>) in chronic immune thrombocytopenia

Olga Arbach, A. B. Taumberger, Stefan Wietek et al. · Transfusion Medicine · 2019 · 14 citations · Full text

Sustained functional benefits after a single set of injections with abobotulinumtoxinA using a 2-mL injection volume in adults with cervical dystonia: 12-week results from a randomized, double-blind, placebo-controlled phase 3b study

Atul T. Patel, Mark Lew, Khashayar Dashtipour et al. · PLoS ONE · 2021 · 10 citations · Full text

Rows per page

1–4 of 4